0002010195-24-000004.txt : 20240318 0002010195-24-000004.hdr.sgml : 20240318 20240318212056 ACCESSION NUMBER: 0002010195-24-000004 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 24760888 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 740 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (415) 655-4168 MAIL ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 740 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Holdings A/S CENTRAL INDEX KEY: 0001388325 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 BUSINESS PHONE: 45 8824 8824 MAIL ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 FORMER COMPANY: FORMER CONFORMED NAME: Novo A/S DATE OF NAME CHANGE: 20070130 144 1 primary_doc.xml 144 0001388325 XXXXXXXX LIVE 0001683553 SPRUCE BIOSCIENCES, INC. 001-39594 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168 Novo Holdings A/S 10% Stockholder Common Stock Morgan Stanley & Co. LLC

1585 Broadway New York NY 10036

4810020 3899002.21 41149160 03/18/2024 NASDAQGS Common Stock 10/14/2020 Conversion of Series A Preferred Stock in Initial Public Offering Spruce Biosciences, Inc. N 1298202 10/14/2020 Conversion of Preferred Stock Common Stock 10/14/2020 Conversion of Series B Preferred Stock in Initial Public Offering Spruce Biosciences, Inc. N 1528818 10/14/2020 Conversion of Preferred Stock Common Stock 10/14/2020 Purchase in Initial Public Offering Underwriters N 250000 10/14/2020 Cash Common Stock 02/16/2023 Purchase in a Private Offering Spruce Biosciences, Inc. N 2208000 02/16/2023 Cash N Morgan Stanley & Co. LLC

1585 Broadway New York NY 10036

Common Stock 03/14/2024 1912316 1698901.53 03/18/2024 /s/ Barbara Fiorini Due, General Counsel, Finance & Operations